European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial
Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial